Takeda Pharmaceutical Company’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.49M Hold
7,531,996
12.71% 2
2025
Q1
$2.35M Hold
7,531,996
14.51% 2
2024
Q4
$7.01M Hold
7,531,996
26.4% 2
2024
Q3
$8.89M Hold
7,531,996
23.42% 3
2024
Q2
$5.79M Hold
7,531,996
2.49% 5
2024
Q1
$23M Hold
7,531,996
7.95% 4
2023
Q4
$24.3M Buy
+7,531,996
New +$24.3M 7.41% 4